Add BrightSurf on Google Email

Duke-NUS Medical School


Discovery of key protein behind cancer relapse and progression can lead to new therapies

The study reveals that low levels of MBNL1 protein are associated with poor overall survival in various common cancers. Blocking the JNK protein can reverse this mechanism, providing a potential biomarker for selecting patients for treatment. Researchers plan to investigate MBNL1's role in colorectal cancer and explore anti-JNK therapies.

SourceDuke-NUS Medical School·JournalProceedings of the National Academy of Sciences·DateJun 30, 2020

Genes tell a story about diabetic kidney disease

Scientists have identified several genes that may be involved in the development of diabetic kidney disease. By analysing Finnish samples with diabetes, researchers found connections between specific proteins and the condition. The study's findings suggest new potential targets for treating diabetic kidney disease.

SourceDuke-NUS Medical School·JournalJournal of the American Society of Nephrology·DateMar 12, 2020

Community health worker-led care improves blood pressure control in hypertensive patients

A multi-country intervention trial found that community health worker-led care led to significant reductions in blood pressure and improved hypertension management. The study, conducted in Bangladesh, Pakistan, and Sri Lanka, showed a 5mmHg decline in systolic blood pressure and better BP control in the intervention group.

SourceDuke-NUS Medical School·JournalNew England Journal of Medicine·DateFeb 19, 2020

Sensory impairment and health expectancy in older adults

Research found that people with sensory impairments can expect fewer years of remaining life with limited physical function and ADLs. Those with both vision and hearing impairments had the greatest reduction in health expectancy, spending nearly one-third of their life with limitation in physical function.

SourceDuke-NUS Medical School·JournalJournal of the American Geriatrics Society·DateAug 15, 2019

Duke-NUS study: Interaction between two immune cell types could be key to better dengue vaccines

A study by Duke-NUS Medical School researchers has identified a key player in the early fight against dengue virus infection: an interaction between two types of immune cells. The discovery sheds light on how the immune system recognizes viruses and could lead to the development of better vaccines for this and similar diseases.

SourceDuke-NUS Medical School·JournalJournal of Clinical Investigation·DateFeb 7, 2019